Archived News and Press Releases | Par Health

News Archive

October 20, 2025

Endo Launches First and Only Generic Version of RAVICTI® (glycerol phenylbutyrate) Oral Liquid in the United States

September 23, 2025

Endo Expands ADRENALIN® Ready-to-Use Premixed Bag Line with Three New Concentrations - Sep 23, 2025

May 15, 2025

Endo Expands ADRENALIN® Ready-to-Use Premixed Bag Line with New Concentration - May 15, 2025

December 10, 2024

Endo Launches Doxycycline for Injection, USP - Dec 10, 2024

December 9, 2024

Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India - Dec 9, 2024

December 2, 2024

Endo Launches ADRENALIN® Ready-to-Use Premixed Bag, the First and Only FDA-Approved, Manufacturer-Prepared Epinephrine Premixed IV Bag - Dec 2, 2024

July 15, 2024

Endo Launches Tiopronin Delayed-Release Tablets, Generic Version of THIOLA EC® - Jul 15, 2024

May 6, 2024

Endo Launches Enhanced TruDelivery® Ready-to-Use Product Line and Platform - May 6, 2024

March 26, 2024

Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS® - Mar 26, 2024

November 2, 2023

Endo Launches Colchicine Capsules, Generic Version of MITIGARE® - Nov 2, 2023

August 31, 2023

Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD) | Mallinckrodt

July 18, 2023

Endo Launches Bivalirudin Injection in Ready-to-Use Vials - Jul 18, 2023

July 15, 2023

Endo and Premier, Inc. Collaborate to Address Pitocin® (oxytocin injection, USP) Shortage - Jul 17, 2023

June 29, 2023

Endo Launches First Generic Version of Noxafil® (posaconazole) Injection - Jun 29, 2023

June 15, 2023

Endo Launches Dexlansoprazole Capsules, Generic Version of Dexilant® - Jun 15, 2023

June 12, 2023

Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe - Jun 12, 2023

May 24, 2023

Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials - May 24, 2023

April 26, 2023

Endo Announces Agreement with Slayback Pharma to Distribute Prevduo™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Product in the U.S. - Apr 26, 2023

April 17, 2023

Endo Announces Launch of Argatroban Injection Through Premier's ProRx® Private-Label Program - Apr 17, 2023

April 3, 2023

Endo Launches Authorized Generic Version of Noxafil® (posaconazole) Oral Suspension - Apr 3, 2023

March 10, 2023

Endo Launches First Generic Version of Pylera® (bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride) Capsules - Mar 10, 2023